miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer
Metrics: PDF 2937 views | HTML 1919 views | ?
Haiyan Li1, Jiao Li2, Song Jia2, Mengying Wu1, Jiahui An1, Qidi Zheng1, Wei Zhang1 and Dongdong Lu1
1 School of Life Science and Technology, Tongji University, Shanghai, China
2 School of Medicine, Tongji University, Shanghai, China
Dongdong Lu, email:
Keywords: microRNA675, lincRNA H19, early growth response protein 1, pyruvate kinase M2, hepatoma
Received: May 19, 2015 Accepted: August 20, 2015 Published: September 10, 2015
microRNAs (miRNAs) are short non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miR675, embedded in H19’s first exon, had been linked to the development of human cancers. Herein, we demonstrate miR675 overexpression promotes and silencing miR675 attenuated liver cancer cell growth in vitro and in vivo. Mechanistically, miR675 inhibits the heterochromatin1 isoform HP1α expression in human liver cancer cells which causes a dramatically decrease of the total histone H3 lysine 9 trimethylation (H3K9me3) , histone H3 lysine 27 trimethylation (H3K27me3) and a increase of histone H3 lysine 27 acetylation(H3K27Ac).Notably, a significant reduction of the H3K9me3 and H3K27me3 and the increment of H3K27Ac occupancy on the promoter region of EGR1 triggers EGR1 transcription, translation, sumoylation and activation which upregulates lincRNA H19. Strikingly, H19 may induce and activate tumor-specific pyruvate kinase M2 (PKM2) which is essential for the Warburg effect in its dimer and for gene expression in its teramer during tumorigenesis. Our results imply that miR675 is involved in the epigenetic regulation of H3K9me3, H3k27me3 and H3K27Ac for gene expression and function during hepatocarcinogenesis (e.g.C-myc,Pim1,Ras,CyclinD1,RB1).These findings sheds light on the significance of miR675-HP1α-EGR1-H19-PKM2 cascade signaling pathway in liver cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.